Physician

Daniel Callaghan

According to 2025 Medicare claims, Daniel Callaghan (NPI: 1629496872) practices dermatology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Adams, CO. This provider's primary affiliated billing organization is ADVANCED DERMATOLOGY OF COLORADO, PC (NPI: 1710370648; TIN: 471404474) and primary practice location at 80260-7453. Callaghan is affiliated with the ilumed, LLC (ACO ID: D0005) and Rancho Health Management, LLC (ACO ID: D0015), participating under the REACH model.

Callaghan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 626 traditional Medicare patients, billed 2,715 HCPCS/CPT codes, and received $1,228,880 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 593 prescription claims across 401 beneficiaries totaling $5,450 in drug costs, led by Cephalexin (Cephalexin). Open Payments data shows 19 records totaling $470. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $54,492 to $1,228,880. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $5,132 to $5,450. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	107	831	$54,492
2020	346	1,391	$258,332
2021	507	2,003	$372,693
2022	571	2,228	$434,192
2023	605	2,112	$651,652
2024	626	2,715	$1,228,880

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	35	$5,132
2016	78	195	$78,379
2017	51	123	$40,154
2018	21	34	$2,400
2019	42	57	$1,652
2020	152	318	$10,061
2021	204	321	$50,331
2022	289	452	$8,275
2023	434	676	$9,318
2024	401	593	$5,450

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	504	621	$487
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	255	360	$335
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	165	186	$197
13121	Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm	96	100	$195
13131	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm	104	108	$159

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cephalexin	Cephalexin	249	1,879	$1,585
Mupirocin	Mupirocin	141	2,786	$1,322
Gentamicin Sulfate	Gentamicin Sulfate	11	209	$411
Doxycycline Hyclate	Doxycycline Hyclate	25	223	$235
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	132	$217

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$470	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Callaghan?

Tedicare shows public-source Medicare data for Daniel Callaghan (NPI 1629496872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Callaghan have ACO affiliation data?

Daniel Callaghan is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005) and Rancho Health Management, LLC (REACH, ACO ID D0015).

What billing organization is linked to Daniel Callaghan?

Daniel Callaghan is linked to ADVANCED DERMATOLOGY OF COLORADO, PC (billing NPI 1710370648) in the available physician profile data.

Does Daniel Callaghan have Open Payments data?

Daniel Callaghan has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.